Precision Ophthalmology 2025 Conference
June 14, 2025, New York City
Precision Ophthalmology 2025: In Our DNA is a one-of-a-kind conference focusing on the most up-to-date research in precision ophthalmology and is geared towards ophthalmologists, vision scientists, ophthalmic geneticists, and trainees of every level. It’s in our DNA to educate others, to provide superlative clinical care and to advance vision science.
Keynote Speakers
|
"Data Science, Artificial Intelligence, and the Future of Ophthalmology: Perspectives from the National Eye Institute" Michael F. Chiang, MD - Director of the National Eye Institute, National Institute of Health |
|
Artificial Intelligence in Precision Medicine Cecilia Lee, MD, MS - Professor, Klorfine Family Endowed Chair, Director of Clinical Research, University of Washington Medicine, Department of Ophthalmology |
|
Regenerative Biology and Medicine Thomas A. Reh, PhD - Professor, Biological Structure, Institute for Stem Cell & Regenerative Medcinie (ISCRM), University of Washington |
|
Complex Genetics and Inheritance in Ophthalmology and Medicine Janey L. Wiggs, MD, PhD - Associate Chief of Ophthalmology Clinical Research, Associate Director of Howe Laboratory, Mass Eye & Ear / Paul Austin Chandler Professor of Ophthalmology, Co-Director of Glaucoma Center of Excellence, Vice Chair of Clinical Research, Associate Director of Ocular Genomics Institute, Harvard Medical School |
|
Patient-Specific Therapies Andrea Califano, PhD - Chair of the Department of Systems Biology, Clyde '56 and Helen Wu Professor of Chemical Biology (in Systems Biology), Professor of Biomedical Informatics and Biochemistry and Molecular Biophysics, Professor of Medicine in the Institute for Cancer Genetics, Department of Systems Biology, CUIMC |
This activity has been approved for 7.0 AMA PRA Category Credits™
Precision Ophthalmology 2025 offers focused programming on different aspects of precision medicine in vision. Additional programming is available for clinicians, who also have the option to register for an extra day. For more information about the program, see the details below.
Thursday, June 12: Focus on Education - John T. Flynn Resident & Fellow Research Day and Graduation
Presenters: CUIMC Students, Residents, Fellows, Postdoctoral Scientists and keynote speaker Dr. Roy Wilson
Audience: CUIMC Learners of all levels, faculty, staff, and alumni
The first day will provide the opportunity for ophthalmology trainees to showcase research and clinical cases. This day is a continuation of our longstanding tradition of honoring Dr. John Flynn’s dedication to teaching the next generation of ophthalmologists. The day will conclude with The John T. Flynn, MD, Memorial Lecture by Dr. Roy Wilson as well as a graduation ceremony and celebration.
Friday, June 13: Focus on Clinical Care - "Not Your Normal Phenotypes: Solving Conundrums by Collaboration"
Presenters: Faculty, Alumni, and Regional Experts
Audience: Clinicians, Clinician Scientists, and Trainees
The second day will provide a unique opportunity for practicing ophthalmologists and trainees to be updated on advanced surgical techniques, enhance their management of complex ophthalmic conditions and surgical complications, and incorporate new diagnostic and perioperative strategies into practice.
Saturday, June 14: Focus on Vision Science - 4th Precision Ophthalmology™ 2025: In Our DNA
Presenters: Columbia Faculty, National & International Experts
Audience: Scientists and Clinicians seeking cutting-edge information about complex genetics and inheritance in ophthalmology and medicine, artificial intelligence in precision medicine, regenerative biology and medicine, & patient-specific therapies
The third day aims to advance knowledge in precision medicine and genetics, particularly within ophthalmology, by highlighting the incorporation of emerging technologies into medicine, including artificial intelligence, stem cell research, and gene-based therapies. This day will equip clinicians and researchers with the knowledge needed to advance patient care and treatment outcomes in the rapidly evolving field of ophthalmic precision medicine.